Related Experiment Video
Updated: Aug 21, 2025
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
MiR-137 targets and regulates E2F7 to suppress progression of glioma cells
Jun Li1, Jingshun Gu1, Juntong Wang1
1The Fourth Department of Neurosurgery, Tangshan Gongren Hospital, Tangshan, Hebei, P.R. China.
Introduction:
The paper aimed to explore the mechanism of miR-137 in modulating glioma.
Material And Methods:
qRT-PCR detected miR-137 and E2F7 mRNA expression in cells. The protein expression of E2F7 was measured using Western blot assay. Cell proliferation, scratch healing, transwell and programmed cell death assays were conducted to examine the influences of the genes on the biological function of glioma cells. The dual-luciferase assay verified the interaction between miR-137 and E2F7.
Results:
MiR-137 was lowly expressed in glioma cells, and E2F7 was highly expressed. MiR-137 suppressed progression and promoted programmed cell death of glioma cells. MiR-137 could target and negatively regulate E2F7 expression to further accelerate programmed cell death of glioma cells.
Conclusions:
It was found that miR-137 could target E2F7 to restrain cell progression and accelerate programmed cell death of glioma cells, which is helpful to search for new molecular therapeutic targets for glioma.
Insights
MicroRNA-137 (miR-137) targets E2F7 to suppress glioma progression and promote cell death. This finding offers potential new therapeutic targets for glioma treatment.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Glioma is a primary brain tumor with complex molecular mechanisms.
- Understanding microRNA involvement in glioma pathogenesis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of microRNA-137 (miR-137) in regulating glioma.
- To elucidate the molecular mechanism by which miR-137 affects glioma cell behavior.
Main Methods:
- Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) for gene expression analysis.
- Western blot assay for protein level determination.
- Cellular assays including proliferation, migration, invasion, and apoptosis.
- Dual-luciferase reporter assay to confirm gene interactions.
Main Results:
- miR-137 expression was significantly downregulated in glioma cells, while E2F7 expression was upregulated.
- miR-137 overexpression inhibited glioma cell proliferation and migration, and induced apoptosis.
- miR-137 directly targets E2F7, negatively regulating its expression.
Conclusions:
- miR-137 acts as a tumor suppressor in glioma by targeting E2F7.
- The miR-137/E2F7 axis represents a promising therapeutic target for glioma treatment.
- Further research into this pathway could lead to novel molecular therapies for glioma.
Related Concept Videos
01:22MicroRNAs
02:38Mitogens and the Cell Cycle
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...